Delivery Order SPE2DB20D2002-SPE2DB24FL83Y

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $11,827.67 contract is for the supply of Trelegy Ellipta 200-62.5-25 60S, a prescription medication, with a period of performance through April 2025. The contract is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Trelegy Ellipta 100-62.5-25 60s, a pharmaceutical product. The $11,517.71 contract has a completion date of January 17, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,156.21, is for the provision of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a $32,579.95 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of Trelegy Ellipta 100-62.5-25 60s, a prescription medication, to support military healthcare programs. The contract has an ultimate completion date of March 6, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract the vendor holds...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $14,061.15 and is for the supply of Trelegy Ellipta 200-62.5-25 60S, a prescription medication. The contract has an ultimate completion date of August 30, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a 60-count package of a specialty pharmaceutical product, with a ceiling value of $7,149.69 and a completion date of August 16, 2023. The contract does not have a set-aside designation, indicating...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,171.77, is for the provision of Trelegy Ellipta 200-62.5-25 60S, a pharmaceutical product. The award has an ultimate completion date of April 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Trelegy Ellipta 100-62.5-25 60s, a prescription medication. The contract is a firm fixed price award with a ceiling value of $2,021.89 and an ultimate completion date of August 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,009.61 contract is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a prescription medication, with a performance period through June 10, 2025. This order is not set aside and is part of AmerisourceBergen Drug Corp's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Trelegy Ellipta 200-62.5-25 60 count prescription medication. The contract has a firm fixed price of $3,416.26 and an ultimate completion date of November 22, 2024. This contract was not set aside for any specific business size or socioeconomic category. The award is part of a larger Indefinite Delivery Contract (IDC) held by...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB24FL83Y
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trelegy Ellipta 200-62.5-25 60S medication. The $3,297.86 contract has an ultimate completion date of September 5, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:46 AM